Antibiotic resistance is outpacing the drugs designed to beat it, and the conventional antibiotic pipeline is no longer enough on its own. But four biotechnological approaches—phage therapy, antimicrobial peptides (AMPs), CRISPR-based antimicrobials, and nanoparticles—attack resistant bacteria in fundamentally different ways. Some work by hitting a chosen pathogen with surgical precision; others by acting broadly or by delivering existing weapons more effectively. Understanding how each one works, and where each one struggles, is the key to seeing where the field is heading and why no single technology will "win" the fight.
The Escalating Threat of Antimicrobial Resistance and the Need for Novel Solutions
Why do we need alternatives to antibiotics at all? Because bacteria adapt. As one review of phage therapy clinical trials puts it, "Infectious diseases continue to plague the world because bacteria can adapt and develop defence mechanisms against antibiotics." The growing incidence of antibiotic-resistant bacterial infections, that review notes, necessitated the development of new treatment techniques worldwide. This is not a hypothetical future problem—it is a present, escalating driver of new research.
A survey of innovative AMR strategies published in the biomedical literature frames the response in similar terms: the growing threat of AMR demands innovative therapeutic strategies beyond conventional antibiotics. Four technologies stand out in that literature—phages, peptides, CRISPR systems, and nanotechnology—each complementing traditional discovery methods while addressing key limitations of conventional antibiotics. The same survey is careful in its language: each approach presents its own "unique advantages and challenges in clinical translation."
That qualification matters. Every one of these technologies is promising in principle and difficult in practice. Their integration into antimicrobial development pipelines, the survey authors argue, offers a comprehensive strategy to combat the escalating AMR crisis—note the plural. The field's working assumption is that these tools will work together, not in isolation.





